SEC Form 4 · accession 0001209191-15-058129
HARVARD BIOSCIENCE INC · HBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey Duchemin
Officer — Chief Executive Officer · Director
Period of report
Jun 30, 2015
Accepted (ET)
Jul 1, 2015 · 5:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001123494
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | Jun 30, 2015 | J | 2,276 | $4.67 | A | 76,462 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares acquired under the Issuer's Employee Stock Purchase Plan.
- F2Represents the purchase price for each share purchased under the Employee Stock Purchase Plan and equals 85% of the fair market value of the common stock on January 1, 2015, being the offering date under the plan.
- F3Includes (a) a deferred stock award of 68,900 restricted stock units which shall vest in four equal installments on January 1, 2016, 2017, 2018 and 2019; and (b) 7,562 shares of common stock held by the Reporting Person.
Remarks
This form is signed under power of attorney.